NHS Branded Medicines Tranche Framework for London and South of England

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Contract (Products)
Duration
2 year
Value
£381M
Sector
HEALTH
Published
20 Aug 2024
Delivery
01 Sep 2024 to 31 Aug 2026
Deadline
05 Apr 2024 12:00

Concepts

Location

Geochart for 1 buyers and 29 suppliers

1 buyer

29 suppliers

Description

NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024 Offer reference number: CM/PHR/22/5689 CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South of England Tranche A. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South of England Tranche B. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5689/03 - NHS Framework for the supply of Omalizumab and Diroximel Fumarate for the Midlands & East and North of England. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Award Detail

1 Sun Pharma (None)
  • Value: £380,950,720
2 Biogen (Maidenhead)
  • Value: £380,950,720
3 Merck Sharpe & Dohme (London)
  • Value: £380,950,720
4 Celltrion Healthcare (Slough)
  • Value: £380,950,720
5 Astrazeneca (London)
  • Value: £380,950,720
6 Janssen Cilag (High Wycombe)
  • Value: £380,950,720
7 Organon Pharmaceuticals (London)
  • Value: £380,950,720
8 Thornton & Ross (Huddersfield)
  • Value: £380,950,720
9 Glaxosmithkline (Great West Road Brentford)
  • Value: £380,950,720
10 Takeda (Kingdom Street London)
  • Value: £380,950,720
11 Pfizer (Tadworth)
  • Value: £380,950,720
12 Novartis Pharmaceuticals (London)
  • Value: £380,950,720
13 Zentiva Pharma (Guildford)
  • Value: £380,950,720
14 Roche Products (Welwyn Garden City)
  • Value: £380,950,720
15 Eli Lilly (Basingstoke)
  • Value: £380,950,720
16 Aventis Pharma (Reading)
  • Value: £380,950,720
17 Accord (Whiddon Valley Barnstaple)
  • Value: £380,950,720
18 Orifarm (None)
  • Value: £380,950,720
19 Galapagos Biotech (Uxbridge)
  • Value: £380,950,720
20 Manx Healthcare (Warwick)
  • Value: £380,950,720
21 Chugai Pharma (Turnham Green London)
  • Value: £380,950,720
22 Napp Pharmaceuticals (Cambridge)
  • Value: £380,950,720
23 Drreddys Laboratories (Cambridge)
  • Value: £380,950,720
24 Leo Pharma (Maidenhead)
  • Value: £380,950,720
25 Gedeon Richter (None)
  • Value: £380,950,720
26 Biosimilar Collaborations Ireland (London)
  • Value: £380,950,720
27 Sobi Swedish Orphan Biovitrum (Great Abington)
  • Value: £380,950,720
28 Teva (Glasshoughton Castleford)
  • Value: £380,950,720
29 Ucb Pharma (Slough)
  • Value: £380,950,720

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

Transparency Award Schedules - London & South of England - CM_PHR_225689_02 Transparency Award Schedules - London & South of England - CM_PHR_225689_02.pdf Transparency Award Schedules - London & South of England - CM_PHR_225689_01 Transparency Award Schedules - London & South of England - CM_PHR_225689_01.pdf Transparency Award Schedules - Omalizumab and Diroximel Fumarate for MAE & NOFE - CM_PHR_225689_03 Transparency Award Schedules - Omalizumab and Diroximel Fumarate for MAE & NOFE - CM_PHR_225689_03.pdf Parties Appointed to Framework Agreement -CM_PHR_22_5689 - London & South of England - 1st September 2024 Parties Appointed to Framework Agreement -CM_PHR_22_5689 - London & South of England - 1st September 2024.doc Framework Agreement and Terms and Conditions - CM_PHR_22_5689 - London & South of England - 1st September 2024 Framework Agreement and Terms and Conditions - CM_PHR_22_5689 - London & South of England - 1st September 2024.pdf

Reference

Domains